KemPharm, Inc. KMPH
Set alert
At close · Feb 28
52-week range unavailable
- Open
- 5.83
- Prev close
- 5.81
- Mkt cap
- 200.47M
- Vol
- 64.13K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.79
- High
- 5.97
- Forward P/E
- -8.54
- Beta
- 2.16
- Short ratio
- 5.87
- Inst. own
- 17.69%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 7, 2023
- 50-d avg
- 5.33
- 200-d avg
- 5.27
- 1y target
- 22.33
News
3 years ago globenewswire.com
Zevra Therapeutics to Report Fourth Quarter and Full-Year 2022 Results
CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (Zevra, or the Company, formerly KemPharm, Inc.), a rare disease therapeutics company, has announced…
3 years ago seekingalpha.com
KemPharm: Now A Rare Disease Play, Upgrading To A Buy Rating
We initiated KemPharm with a Sell rating in March 2021; since then, the stock has declined >40%, and now the stock is trading at an attractive enterprise value of $130m. AZSTARYS targeting ADHD has…
3 years ago seekingalpha.com
KemPharm, Inc. (KMPH) Q3 2022 Earnings Call Transcript
KemPharm, Inc. (NASDAQ:KMPH ) Q3 2022 Results Conference Call November 9, 2022 5:00 PM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Travis Mickle - President and…
-
3 years ago benzinga.com
Earnings Scheduled For November 9, 2022
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
4 years ago zacks.com
KemPharm (KMPH) Up On Positive Data From Sleep Disorder Study
KemPharm (KMPH) reports positive top line from a study evaluating serdexmethylphenidate (SDX) for cardiovascular safety to progress the development of its prodrug KP1077.
-
4 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
Upgrades
4 years ago globenewswire.com
KemPharm to Present at the H.C. Wainwright 24th Annual Global Investment Conference
CELEBRATION, Fla., Sept. 01, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and…
4 years ago seekingalpha.com
KemPharm, Inc. (KMPH) CEO Travis Mickle on Q2 2022 Results - Earnings Call Transcript
KemPharm, Inc. (NASDAQ:KMPH ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Nichol Ochsner - Vice President-Investor Relations & Corporate Communications Travis…
-
4 years ago benzinga.com
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
4 years ago globenewswire.com
KemPharm to Present at the Canaccord Genuity 42nd Annual Growth Conference
CELEBRATION, Fla., Aug. 02, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and…
4 years ago globenewswire.com
Orphazyme completes sale of substantially all of its assets and business activities to KemPharm
Orphazyme A/SCompany announcement No. 29/2022 Inside information www.orphazyme.com Company Registration No. 32266355
4 years ago zacks.com
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
4 years ago globenewswire.com
Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc.
Orphazyme A/S in restructuring Company announcement No. 24/2022Inside information www.orphazyme.com Company Registration No. 32266355
4 years ago seekingalpha.com
KemPharm, Inc. (KMPH) CEO Travis Mickle on Q1 2022 Results - Earnings Call Transcript
KemPharm, Inc. (NASDAQ:KMPH ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Travis Mickle - Co-Founder, President, CEO & Director LaDuane Clifton - CFO, Secretary &…
-
4 years ago benzinga.com
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
4 years ago zacks.com
KemPharm (KMPH) Starts Early-Stage Cardiovascular Safety Study
KemPharm (KMPH) initiates dosing in a phase I study to evaluate the cardiovascular safety profile of its lead pipeline candidate, KP1077's sole active API, serdexmethylphenidate.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 466 companies hit new 52-week lows.
4 years ago seekingalpha.com
KemPharm, Inc. (KMPH) CEO Travis Mickle on Q4 2021 Results - Earnings Call Transcript
KemPharm, Inc. (KMPH) CEO Travis Mickle on Q4 2021 Results - Earnings Call Transcript
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 671 companies achieved new lows for the year.
4 years ago globenewswire.com
KemPharm to Report Fourth Quarter and Full-Year 2021 Results
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, March 30, 2022, 5:00 p.m. ET
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 524 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 115 companies reached new 52-week lows.
4 years ago benzinga.com
KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder
KemPharm Inc (NASDAQ: KMPH) has selected KP1077 for idiopathic hypersomnia (IH) as its lead serdexmethylphenidate (SDX) candidate in the pipeline. Idiopathic hypersomnia is an uncommon sleep disorder…
4 years ago globenewswire.com
KemPharm to Host Investor Conference Call Detailing Plans for Pipeline Expansion
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, January 19, 2022 at 4:30 p.m. ET
4 years ago zacks.com
Implied Volatility Surging for KemPharm (KMPH) Stock Options
Investors need to pay close attention to KemPharm (KMPH) stock based on the movements in the options market lately.
4 years ago seekingalpha.com
KemPharm's (KMPH) CEO Travis Mickle on Q3 2021 Results - Earnings Call Transcript
KemPharm's (KMPH) CEO Travis Mickle on Q3 2021 Results - Earnings Call Transcript
-
4 years ago benzinga.com
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
4 years ago globenewswire.com
KemPharm to Report Third Quarter 2021 Results
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, November 10, 2021, 4:30 p.m. ET
5 years ago globenewswire.com
KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market
Trading to commence effective with the open of business on October 19, 2021
-
5 years ago benzinga.com
78 Biggest Movers From Friday
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
-
5 years ago benzinga.com
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
-
5 years ago benzinga.com
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
-
5 years ago benzinga.com
Earnings Scheduled For March 11, 2021
Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quarterly earnings at $0.02 per share on revenue of $34.63 million.
-
5 years ago benzinga.com
82 Biggest Movers From Yesterday
Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares surged 78.7% to close at $38.00 on Thursday after Amgen announced plans to acquire the company for $1.9 billion.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday morning, 198 companies hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
This morning 533 companies reached new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Monday morning saw 558 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
During the morning session on Monday, 372 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2021
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2021
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
This morning 127 companies reached new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 23rd
Stocks Which Set New 52-Week Low Yesterday, October 23rd
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 11th
Stocks Which Set New 52-Week Low Yesterday, October 11th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Friday, October 5th
Stocks Which Set New 52-Week Low Friday, October 5th